7 Results for "

rapamycin analog

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "rapamycin analog" in MCE Product Catalog:

Cat. No.: HY-12424A
CAS No.: 221877-56-1
Purity:  98.07%
Target:  

Drug Intermediate

Research Areas:  

Cancer

42-(2-Tetrazolyl)rapamycin is a proagent compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor.
loading...
    loading...
Cat. No.: HY-106345
CAS No.: 892494-07-4
ILS-920 is a nonimmunosuppressive Rapamycin analog with reduced immunosuppressive activity and potent neuroprotective activity. ILS-920 binds selectively to the immunophilin FKBP52 and to the β1-subunit of L-type voltage-gated calcium channels (VGCC). ILS-920 shows 200-fold selectivity for FKBP52 versus FKBP12 .
loading...
    loading...
Cat. No.: HY-153511
CAS No.: 2357217-22-0
Target:  

Drug Derivative

Research Areas:  

Cancer

Rapamycin analog-2 (compound A) is a Rapamycin analog .
loading...
    loading...
Cat. No.: HY-139085A
Purity:  ≥95.0%
Target:  

Drug Intermediate

Research Areas:  

Cancer

XL388-C2-amide-PEG9-NH2 hydrochloride is an intermediate used in the synthesis of C26-linked Rapamycin analog .
loading...
    loading...
Cat. No.: HY-139085B
Target:  

Drug Intermediate

Research Areas:  

Cancer

XL388-C2-amide-PEG9-NH2 TFA is an intermediate used in the synthesis of C26-linked Rapamycin analog .
loading...
    loading...
Cat. No.: HY-176947
CAS No.: 1887095-85-3
Target:  

Drug Intermediate

Research Areas:  

Cancer

Demethyl-sapanisertib-C2-amide-PEG7-C2-N3 (Compound 10c) is an azide group linker used for coupling, which can be employed in the synthesis of "Rapa-Link" compounds, such as M-1111 (HY-176948), an mTOR inhibitor .
loading...
    loading...
Cat. No.: HY-176948
CAS No.: 1887095-86-4
Target:  

mTOR

Research Areas:  

Cancer

M-1111 is a Rapa-Link inhibitor. M-1111 is covalently linked by Rapamycin (HY-10219) and an inhibitor of the active site mTOR. M-1111 has strong inhibitory activity on the mTORC1 signaling pathway (pS6 and p4E-BP1). M-1111 has nanomolar-level inhibitory activity against various cancer cells. M-1111 completely inhibits p4E-BP1 without inhibiting pAkt S473. M-1111 can be used for research on liver cancer, kidney cancer, and colorectal cancer .
loading...
    loading...